Numinus Wellness Full Year 2023 Earnings Misses Expectations - Simply Wall St

LOBEF Stock  USD 0.02  0.01  784.21%   
Roughly 57% of all Lobe Sciences' stockholders are looking to take a long position. The analysis of current outlook of investing in Lobe Sciences suggests that some traders are interested regarding Lobe Sciences' prospects. The current market sentiment, together with Lobe Sciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Lobe Sciences stock news signals to limit their universe of possible portfolio assets.
Lobe Sciences otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Lobe daily returns and investor perception about the current price of Lobe Sciences as well as its diversification or hedging effects on your existing portfolios.
  
Numinus Wellness Full Year 2023 Earnings Misses Expectations Simply Wall St

Read at news.google.com
Google News at Macroaxis
  

Lobe Sciences Fundamental Analysis

We analyze Lobe Sciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Lobe Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Lobe Sciences based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

Lobe Sciences is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Peers

Trending Equities

INTC  3.48   
0%
100.0%
AAL  2.19   
0%
62.0%
WFC  2.16   
0%
62.0%
HD  1.97   
0%
56.0%
AA  1.96   
0%
56.0%
CVS  1.32   
0%
37.0%
C  1.13   
0%
32.0%
S  0.45   
0%
12.0%
MET  0.43   
0%
12.0%
T  0.40   
0%
11.0%
TGT  0.33   
0%
9.0%
AAPL  0.31   
0%
8.0%
CVX  0.08   
0%
2.0%
UPS  0.06   
0%
1.0%
BBY  0.27   
7.0%
0%
IBM  0.64   
18.0%
0%

Complementary Tools for Lobe OTC Stock analysis

When running Lobe Sciences' price analysis, check to measure Lobe Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lobe Sciences is operating at the current time. Most of Lobe Sciences' value examination focuses on studying past and present price action to predict the probability of Lobe Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lobe Sciences' price. Additionally, you may evaluate how the addition of Lobe Sciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk